Catalyst Wire Dossier Catalyst Wire Dossier

Ibuprofen 4% (w/v) formulation

ibuprofen · Reckitt Benckiser Healthcare (UK) Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ibuprofen 4% (w/v) formulation, covering 2019-06-05 to 2019-06-05. Get the full timeline:

Most recent: Clinical Trial Update: Ibuprofen 4% (w/v) Pivotal Bioequivalence Study [Phase 1]

See pricing